|
1AUK
HUMAN ARYLSULFATASE A
Deposited 1997-08-29
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
19–507(489 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.4;291 K;PROTEIN WAS CRYSTALLIZED BY VAPOR DIFFUSION IN HANGING DROPS AT 291 K. SOLUTION CONTAINING 10MG/ML PROTEIN, 10 MM TRIS/HCL (PH 7.4) AND 150 MM NACL WAS MIXED WITH SAME VOLUME OF RESERVOIR SOLUTION, CONTAINING 100 MM NA-ACETATE (PH 5.0 - 5.4) AND 10 - 13 % PEG 6000, vapor diffusion - hanging drop
|
Resolution 2.10 Å
R-free 0.273
|
|
1E1Z
Crystal structure of an Arylsulfatase A mutant C69S
Deposited 2000-05-12
|
Different mutation/modification
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain P
19–507(489 aa)
|
Mutation:C69S
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.4;291 K;PROTEIN WAS CRYSTALLIZED BY VAPOR DIFFUSION IN HANGING DROPS AT 291 K. SOLUTION CONTAINING 10MG/ML PROTEIN, 10 MM TRIS/HCL (PH 7.4) AND 150 MM NACL WAS MIXED WITH SAME VOLUME OF RESERVOIR SOLUTION, CONTAINING 100 MM NA-ACETATE (PH 5.0 - 5.4) AND 10 - 13 % PEG 6000
|
Resolution 2.40 Å
R-free 0.243
|
|
1E2S
Crystal structure of an Arylsulfatase A mutant C69A
Deposited 2000-05-24
|
Different mutation/modification
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain P
19–507(489 aa)
|
Mutation:C69A
|
MG MAGNESIUM ION × 2
CSN N,4-DIHYDROXY-N-OXO-3-(SULFOOXY)BENZENAMINIUM × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.4;291 K;PROTEIN WAS CRYSTALLIZED BY VAPOR DIFFUSION IN HANGING DROPS AT 291 K. SOLUTION CONTAINING 10MG/ML PROTEIN, 10 MM TRIS/HCL (PH 7.4) AND 150 MM NACL WAS MIXED WITH SAME VOLUME OF RESERVOIR SOLUTION, CONTAINING 100 MM NA-ACETATE (PH 5.0 - 5.4) AND 10 - 13 % PEG 6000
|
Resolution 2.35 Å
R-free 0.236
|
|
1E3C
Crystal structure of an Arylsulfatase A mutant C69S soaked in synthetic substrate
Deposited 2000-06-13
|
Different mutation/modification
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain P
19–507(489 aa)
|
Mutation:C69S
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.4;291 K;PROTEIN WAS CRYSTALLIZED BY VAPOR DIFFUSION IN HANGING DROPS AT 291 K. SOLUTION CONTAINING 10MG/ML PROTEIN, 10 MM TRIS/HCL (PH 7.4) AND 150 MM NACL WAS MIXED WITH SAME VOLUME OF RESERVOIR SOLUTION, CONTAINING 100 MM NA-ACETATE (PH 5.0 - 5.4) AND 10 - 13 % PEG 6000
|
Resolution 2.65 Å
R-free 0.243
|
|
1N2K
Crystal structure of a covalent intermediate of endogenous human arylsulfatase A
Deposited 2002-10-23
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
19–507(489 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;cacodylate, sodium fluoride, PEG8000, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.75 Å
R-free 0.239
|
|
1N2L
Crystal structure of a covalent intermediate of endogenous human arylsulfatase A
Deposited 2002-10-23
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
19–507(489 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;cacodylate, sodium fluoride, PEG8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.20 Å
R-free 0.223
|
|
2AIJ
Formylglycine generating enzyme C336S mutant covalently bound to substrate peptide CTPSR
Deposited 2005-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
69–73(5 aa)
|
Not recorded
|
CA CALCIUM ION × 2
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;PEG 4000, Calcium chloride, TRIS, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.55 Å
R-free 0.178
|
|
2AIK
Formylglycine generating enzyme C336S mutant covalently bound to substrate peptide LCTPSRA
Deposited 2005-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
68–74(7 aa)
|
Not recorded
|
CA CALCIUM ION × 2
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;PEG 4000, Calcium chloride, TRIS, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.73 Å
R-free 0.174
|